BETA: Please send your feedback!
Sumitomo
8053-JP:TKS
Wholesale Distributors
—
LARGE cap
(—)
—
since start of 2019
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 3
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Other
Founded 1998
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Kazuo Ohmori | Chairman | Male |
| Kuniharu Nakamura | President & Representative Director | Male |
| Hideki Iwasawa | Representative Director & Head-Human Resources | Male |
| Koichi Takahata | CFO, Representative Director & Head-Accounting | Male |
| Reiji Morooka | Manager-Accounting & Investor Relations Contact | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 3
Corcept Therapeutics - Competitors and Related Companies
How Corcept Therapeutics stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Corcept Therapeutics
CORT:NAS
Pharmaceuticals: Other
$0
SMALL cap
$12.54
(-0.21%)
-0.09%
since start of 2019
18.45
Loading…